接种Vaxzevria（牛津-阿斯利康）新冠疫苗后新发皮肤扁平苔藓
New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination.
作者信息
Muftah Amira, Lee Stephen, Abbas Mariam
机构信息
Department of Dermatology, College of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Infectious Diseases, College of Medicine, University of Saskatchewan, Regina, SK, Canada.
出版信息
SAGE Open Med Case Rep. 2024 Dec 20;12:2050313X241307109. doi: 10.1177/2050313X241307109. eCollection 2024.
We report a 56-year-old male who developed cutaneous lichen planus (LP) following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination. Multiple topical and systemic therapies were tried with limited success; however, partial improvement was observed with narrow-band UVB (NB-UVB) phototherapy. This report adds to the growing evidence of new-onset LP following COVID-19 vaccination and underscores the need for careful reporting, monitoring, and management of vaccine-related adverse effects.
我们报告了一名56岁男性，他在接种Vaxzevria（牛津-阿斯利康）新冠疫苗后出现了皮肤扁平苔藓（LP）。尝试了多种局部和全身治疗方法，但效果有限；然而，窄谱中波紫外线（NB-UVB）光疗观察到了部分改善。本报告进一步证明了新冠疫苗接种后新发LP的证据不断增加，并强调了对疫苗相关不良反应进行仔细报告、监测和管理的必要性。
Zotero 插件